The pro-tumorigenic responses in metastatic niches: an immunological perspective

被引:0
|
作者
Mohammad Hossein Mirzapour
Mahsa Heidari-Foroozan
Sepideh Razi
Nima Rezaei
机构
[1] Isfahan University of Medical Sciences,School of Medicine
[2] Universal Scientific Education and Research Network (USERN),Cancer Immunology Project (CIP)
[3] Shahid Beheshti University of Medical Sciences,Student Research Committee, School of Medicine
[4] Iran University of Medical Sciences,School of Medicine
[5] Tehran University of Medical Sciences,Research Center for Immunodeficiencies, Children’s Medical Center
[6] Tehran University of Medical Sciences,Department of Immunology, School of Medicine
[7] Universal Scientific Education and Research Network (USERN),Cancer Immunology Project (CIP)
来源
关键词
Cancer immunology; Metastasis; Pre-metastatic niches; Tumorigenesis; Immune cells; Stromal cells;
D O I
暂无
中图分类号
学科分类号
摘要
Metastasis is the leading cause of mortality related to cancer. In the course of metastasis, cancer cells detach from the primary tumor, enter the circulation, extravasate at secondary sites, and colonize there. All of these steps are rate limiting and decrease the efficiency of metastasis. Prior to their arrival, tumor cells can modify the secondary sites. These favorable microenvironments increase the probability of successful dissemination and are referred to as pre-metastatic niches. Cancer cells use different mechanisms to induce and maintain these niches, among which immune cells play prominent roles. The immune system, including innate and adaptive, enhances recruitment, extravasation, and colonization of tumor cells at distant sites. In addition to immune cells, stromal cells can also contribute to forming pre-metastatic niches. This review summarizes the pro-metastatic responses conducted by immune cells and the assistance of stromal cells and endothelial cells in the induction of pre-metastatic niches.
引用
收藏
页码:333 / 344
页数:11
相关论文
共 50 条
  • [1] The pro-tumorigenic responses in metastatic niches: an immunological perspective
    Mirzapour, Mohammad Hossein
    Heidari-Foroozan, Mahsa
    Razi, Sepideh
    Rezaei, Nima
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (02): : 333 - 344
  • [2] Pro-tumorigenic AMPK in glioblastoma
    Leli, Nektaria Maria
    Koumenis, Constantinos
    NATURE CELL BIOLOGY, 2018, 20 (07) : 736 - 737
  • [3] Pro-tumorigenic AMPK in glioblastoma
    Nektaria Maria Leli
    Constantinos Koumenis
    Nature Cell Biology, 2018, 20 : 736 - 737
  • [4] Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site
    Nasrollahzadeh, Elaheh
    Razi, Sepideh
    Keshavarz-Fathi, Mahsa
    Mazzone, Massimiliano
    Rezaei, Nima
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (09) : 1673 - 1697
  • [5] Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site
    Elaheh Nasrollahzadeh
    Sepideh Razi
    Mahsa Keshavarz-Fathi
    Massimiliano Mazzone
    Nima Rezaei
    Cancer Immunology, Immunotherapy, 2020, 69 : 1673 - 1697
  • [6] Lumican, pro-tumorigenic or anti-tumorigenic: A conundrum
    Appunni, Sandeep
    Rubens, Muni
    Ramamoorthy, Venkataraghavan
    Anand, Vivek
    Khandelwal, Madhuram
    Saxena, Anshul
    McGranaghan, Peter
    Odia, Yazmin
    Kotecha, Rupesh
    Sharma, Alpana
    CLINICA CHIMICA ACTA, 2021, 514 : 1 - 7
  • [7] hypoxia controls the glycobiological signature and related pro-tumorigenic properties of metastatic melanomas
    Chakraborty, Asmi
    Perez, Mariana
    Mohammed, Norhan B. B.
    Antonopoulos, Aristotelis
    Ortega, Liettel
    Wells, Michael
    Carroll, Jordan D.
    Staudinger, Caleb
    Marrero, Cristina
    Jimenez, Ramon
    Wilmott, James S.
    Thompson, John F.
    Wang, Wei
    Scolyer, Richard A.
    Murphy, George F.
    Haslam, Stuart M.
    Dimitroff, Charles J.
    GLYCOBIOLOGY, 2021, 31 (12) : 1683 - 1684
  • [8] Osteoprotegerin is a Pro-tumorigenic Factor for Pancreatic Cancer
    Morvaridi, S. K.
    Kanzaki, H.
    Edderkaoui, M.
    Pandol, S. J.
    Murali, R.
    PANCREAS, 2014, 43 (08) : 1392 - 1393
  • [9] The pro-tumorigenic host response to cancer therapies
    Shaked, Yuval
    NATURE REVIEWS CANCER, 2019, 19 (12) : 667 - 685
  • [10] The pro-tumorigenic host response to cancer therapies
    Yuval Shaked
    Nature Reviews Cancer, 2019, 19 : 667 - 685